Highlights
NASDAQ: VCEL       Vericel Corproation
Last Price Today's Change   Day's Range   Trading Volume
41.23   +1.55 (3.91%)  39.16 - 41.31  574,700

Overview

 
Avg Volume (4 weeks):650,772
4 Weeks Range:28.39 - 41.31
4 Weeks Price Volatility (%):
99.38%
52 Weeks Range:6.78 - 41.31
52 Weeks Price Volatility (%):
99.77%
Average Price Target:-

Headlines



No recent Headlines for this stock.


Business Background

Vericel Corp is a fully integrated, commercial-stage biopharmaceutical company dedicated to the identification, development, and commercialization of innovative therapies that enable the body to repair and regenerate damaged tissues and organs to restore normal structure and function. Vericel has marketed products and the goal is to become the leader in cell therapy and regenerative medicine by developing, manufacturing and marketing best-in-class therapies for patients with significant unmet medical needs. The Company operates in one reportable segment: the research, product development, manufacture and distribution of patient-specific, expanded cellular therapies for use in the treatment of specific diseases.

  Be the first to like this.
 


APPS
I3 Messenger
Individual or Group chat with anyone on I3investor
 
 

6239  2800  512  101 

ActiveGainersLosers
Top 10 Active Counters
 NameLastChange 
 AMC 3.51+0.60 
 CTRM 0.405-0.008 
 ADMP 1.79-0.54 
 GME 65.01+22.42 
 SNDL 0.645+0.003 
 AZRX 1.84+0.62 
 PLTR 32.58+6.73 
 SENS 2.31+0.08 
 MKD 1.53+0.64 
 NIO 61.95+3.00